Capital Fund Management S.A. decreased its holdings in shares of MaxLinear, Inc. (NASDAQ:MXL – Free Report) by 31.4% in the fourth quarter, HoldingsChannel reports. The fund owned 91,841 shares of the semiconductor company’s stock after selling 42,135 shares during the quarter. Capital Fund Management S.A.’s holdings in MaxLinear were worth $1,817,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Aster Capital Management DIFC Ltd purchased a new position in MaxLinear during the fourth quarter valued at $34,000. Pacer Advisors Inc. lifted its position in shares of MaxLinear by 29.0% during the 4th quarter. Pacer Advisors Inc. now owns 1,968 shares of the semiconductor company’s stock valued at $39,000 after buying an additional 443 shares in the last quarter. R Squared Ltd purchased a new position in shares of MaxLinear during the 4th quarter valued at about $45,000. Wealthfront Advisers LLC bought a new position in shares of MaxLinear during the 4th quarter valued at approximately $45,000. Finally, Larson Financial Group LLC increased its holdings in MaxLinear by 3,092.0% in the 4th quarter. Larson Financial Group LLC now owns 2,809 shares of the semiconductor company’s stock worth $56,000 after acquiring an additional 2,721 shares in the last quarter. 90.79% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
MXL has been the topic of several analyst reports. Northland Securities lifted their price target on shares of MaxLinear from $25.00 to $27.50 and gave the company an “outperform” rating in a report on Monday, January 6th. Benchmark cut their price target on MaxLinear from $28.00 to $20.00 and set a “buy” rating for the company in a research note on Tuesday. Wells Fargo & Company upped their price objective on MaxLinear from $19.00 to $20.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 30th. Susquehanna decreased their target price on MaxLinear from $25.00 to $23.00 and set a “neutral” rating on the stock in a research note on Thursday, January 30th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of MaxLinear in a research note on Thursday, January 30th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $24.36.
MaxLinear Trading Up 5.4 %
Shares of MXL opened at $10.43 on Wednesday. The stock has a market capitalization of $882.73 million, a PE ratio of -3.56 and a beta of 1.82. The company’s fifty day moving average is $13.24 and its 200 day moving average is $15.97. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.28 and a current ratio of 1.77. MaxLinear, Inc. has a fifty-two week low of $8.35 and a fifty-two week high of $26.59.
MaxLinear (NASDAQ:MXL – Get Free Report) last posted its earnings results on Wednesday, January 29th. The semiconductor company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.14). MaxLinear had a negative return on equity of 21.94% and a negative net margin of 68.01%. Sell-side analysts expect that MaxLinear, Inc. will post -0.37 earnings per share for the current fiscal year.
MaxLinear Profile
MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.
Featured Articles
- Five stocks we like better than MaxLinear
- Breakout Stocks: What They Are and How to Identify Them
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- Investing in Travel Stocks Benefits
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- How to Invest in Biotech Stocks
- Congress! Who Traded What During the Tariff-Induced MeltdownÂ
Want to see what other hedge funds are holding MXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MaxLinear, Inc. (NASDAQ:MXL – Free Report).
Receive News & Ratings for MaxLinear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxLinear and related companies with MarketBeat.com's FREE daily email newsletter.